BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Li H, Lv X, Hu L, Li W, Zi M, He Y. Impact of Diets on Response to Immune Checkpoint Inhibitors (ICIs) Therapy against Tumors. Life 2022;12:409. [DOI: 10.3390/life12030409] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Yu I, Dakwar A, Takabe K. Immunotherapy: Recent Advances and Its Future as a Neoadjuvant, Adjuvant, and Primary Treatment in Colorectal Cancer. Cells 2023;12. [PMID: 36672193 DOI: 10.3390/cells12020258] [Reference Citation Analysis]
2 Pietrzak B, Tomela K, Olejnik-schmidt A, Galus Ł, Mackiewicz J, Kaczmarek M, Mackiewicz A, Schmidt M. A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition. Cancers 2022;14:5369. [DOI: 10.3390/cancers14215369] [Reference Citation Analysis]
3 Shao Y, Cao W, Gao X, Tang M, Zhu D, Liu W. Pretreatment "prognostic nutritional index" as an indicator of outcome in lung cancer patients receiving ICI-based treatment: Systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e31113. [PMID: 36316884 DOI: 10.1097/MD.0000000000031113] [Reference Citation Analysis]